Globus Medical (GMED) Intangibles (2011 - 2026)

Globus Medical (GMED) has reported Intangibles for 16 consecutive years, with $692.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Intangibles fell 13.03% year-over-year to $692.6 million; the trailing twelve-month figure through Jun 2026 stood at $692.6 million (down 13.03% YoY), and the FY2025 full-year result was $745.1 million, down 6.3% from the prior year.
• Intangibles declined to $692.6 million in Q2 2026 per GMED's latest filing, from $720.8 million in the prior quarter.
• Across five years, Intangibles topped out at $1.3 billion in Q3 2023 and bottomed at $54.1 million in Q3 2022.
• Historically, Intangibles has averaged $579.7 million across 5 years, with a median of $758.4 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Intangibles soared 2233.86% in 2023, then sank 33.2% in 2024.
• Over 5 years, Intangibles stood at $63.6 million in 2022, then jumped by 1354.37% to $924.6 million in 2023, then retreated by 14.0% to $795.1 million in 2024, then retreated by 6.3% to $745.1 million in 2025, then fell by 7.04% to $692.6 million in 2026.
• According to Business Quant data, Intangibles over the past three periods registered $692.6 million, $720.8 million, and $745.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.